FDA Investigator Tracy R Ball

Tracy R Ball has conducted inspections on 287 sites in 7 countries as of 24 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
287
Last Inspection Date:
24 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100001492
Countries of Inspections:
United States of America, Argentina, Denmark, Poland, Canada, United Kingdom of Great Britain and Northern Ireland, Spain
FDA Investigators that have inspected at least one site in common with Tracy R Ball:
Aaron P Wozniak, Abdur Rashid, Adam R Cooke, Alaric C Denton, Alphonso A Haupt, III, Althea A Williams, Amy H Ruble, Andrace L Deyampert, Andrea L Williams Jones, Angelica M Hernandez, Ann B Borromeo, Anna M Brannen, Anthony J Grace, Arthur G Hurst, Barbara A Rusin, Barbara M Frazier, Barbara T Carmichael, Betsy C Galliher, Bonita S Chester, Brandy D Brown, Brentley S Collins, Brett D Weed, Brett Weed, Brian A Graves, Brian R Yaun, Burnell M Henry, Cara Fiore, PhD, Cara M Minelli, Carl E Lovrich, Carlos A Ortiz, Carol F Robinson, Cassandra L Abellard, CDR Thomas R Berry, PPh, Cheryl A Grandinetti, Cheryl D Barton, Cheryl Love Harris, Chris Alexander, Christine M O'leary, Christopher S Keating, Claudette D Brooks, Constance Y Fears, Cordelia J Brammer, Cynthia F Kleppinger, MD, Daphne Santiago, PhD, David E Lowe, David T Glover, David Williams, Dawn M Braswell, Deborah A Greco, Deborah M Trout, Debra J Tucker, Dellarese L Herbert, Derek C Price, Devaughn Edwards, Deyaa Shaheen, Diane Hall, Doretha M Tonkins, Doretha M Wilson, Douglas L Page, Dr. Jason R Caballero, Dr. Koffi A Amegadje, Edecia A Richards, Edward Deberry, Edward Lukeman, Eileen J Bannerman, Eileen T Monaghan, Eric S Weilage, Ernest H Blackwood, Esra Toussaint, Frank Wackes, Gabriel R Mclemore, Gamal A Norton, Gates E Raynor, George G Calafactor, Gideon N Esuzor, Hai Lient Phung, Harshal J Desai, Helen R Bester, Hristu B Chepa, Ibad U Khan, Jacqueline Mdiaz Albertini, James P Lewis, Jr, Janet B Gray, Janete F Guardia, Jared P Stevens, Jason F Chancey, Jason K Morgan, Jawaid Hamid, Jeff M Uriarte, Jennifer D Hollstrom, Jessica A Stephens, Jessica D Weber, Jessica Fields, Jianyang Wang, Jie He, Joanne T Gabay, John E Aghadia, Johnson, Jonathan G Swoboda, Joseph F Owens, Joyce A Rockwell, Kara D Dobbin, Kassa Ayalew, MD, Katelynn J Rollins, Kathleen D Culver, Kemejumaka N Opara, Kenneth L Smalls, Kevin J Matthews, Khalid M Khan, Kimberly Cdelk Brooks, Kip J Hanks, Lareese K Thomas, Larry K Hampton, Lauryl A Smith, Leon L Crawley, Leslie W Gilbert, Lewis K Antwi, Lillie D Witcher, Lisa P Oakes, Lorenzo Jones, LT Daveta L Bailey, LT Tamara J Henderson, Mancia R Walker, Marie F Morin, Marla A Cassidy, Mary Alice Papadimitriou, Mary T Carden, Megan T Ziegler, Metitia G Sanders, Metitia M Gramby, Miaja Umaedi, Michelle D Haamid, Michelle L Jones, Morrell, Nancy E Fontaine, Nicholas M Smith, Nicole K Trudel, Nicole M Bell, Nigel L Hirth, Noreen Muñiz, Omotunde O Osunsanmi, Pamela L Velez Vega, Paul W Moy, Paula J Bretz, Penny H Mccarver, Philip Campbell, Rachael A Moliver, Rachael L Cook, Rachel M Skeete, Randy D Baxter, Randy L Clarida, Rashard A Knight, Rashonda N Rucker, Reba A Gates, Rebecca Rodriguez, Regan T Harp, Richard J Bashay, Richard L Garcia, Robert C Coleman, Robert L Lewis, Jr, Robin N Goins, Ronit Jolles Mazor, Rosia E Nesbitt, Samantha J Bradley, Sarah L Holliday, Scott E Norris, Seneca D Toms, Sereen Gmorgan Murray, Sharna D Pratt, Sherri J Jackson, Simone E Pitts, Sonya M Edmonds, Steven D Banks, Susan M Jackson, Susan O Oladeji, Tajah L Blackburn, Tamara M Casselman, Thomas D Clarida, Thomas W Nojek, Tracy L Ramseur, Trang N Cox, Tyrico K English, Vanessa E Coulter, Veronica Fuentes, MS, Vicky C Stoakes, Viviana Matta, William P Tonkins, Xiomara Copeland, Yiyue Zhang (nmi), PhD, Youmin Wang

Tracy R Ball's Documents

Publish Date Document Type Title
September, 2009 FDA 483 CSL Plasma, Inc - Form 483, 2009-09-18
May, 2002 FDA 483 Frenette, Gary MD - Form 483, 2002-05-28
July, 2009 FDA 483 Terry Arnold, M.D. - Form 483, 2009-07-22
June, 2016 EIR Mohammed Alhatou - EIR, 2016-06-16
December, 2003 FDA 483 Response Ei, LLC - Form 483R, 2004-01-20
February, 2001 EIR Leiner Health Product, Llc - EIR, 2001-02-01
December, 2012 EIR Custom Analytics LLC - EIR, 2012-12-11
July, 2001 EIR McKesson Corporation - EIR, 2001-07-02
January, 2012 EIR Chelsea Therapeutics Inc - EIR, 2012-01-19
August, 2004 FDA 483 SC Johnson Professional USA, Inc. - Form 483, 2004-08-18
February, 2001 FDA 483 Leiner Health Product, Llc - Form 483, 2001-02-01
February, 2018 EIR GW RESEARCH LTD - EIR, 2018-02-02
March, 2002 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2002-03-22
June, 2002 EIR Ei, LLC - EIR, 2002-06-14
September, 2013 FDA 483 SC Johnson Professional USA, Inc. - Form 483, 2013-09-24
June, 2000 FDA 483 Heyder, Albrecht - Form 483, 2000-06-10
November, 2000 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2000-11-21
January, 2005 EIR Ei, LLC - EIR, 2005-01-14
February, 2000 EIR Marc T. Silver, MD - EIR, 2000-02-01
April, 2004 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2004-04-02
June, 2000 EIR Heyder, Albrecht - EIR, 2000-06-09
July, 2011 EIR SpecGx LLC - EIR, 2011-07-21
August, 2000 EIR Rotberg, Michael - EIR, 2000-08-03
October, 2015 EIR Patheon Softgels Inc. - EIR, 2015-10-05
December, 2003 FDA 483 Ei, LLC - Form 483, 2003-12-23
October, 2002 EIR GlaxoSmithKline LLC - EIR, 2002-10-17
October, 2000 FDA 483 American National Red Cross (The) Carolinas Region - Form 483, 2000-07-26
September, 2012 EIR Akesis, LLC - EIR, 2012-09-14
November, 2000 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2000-11-21
March, 2024 FDA 483 Wake Forest University Health Sciences RDRC - Form 483, 2024-03-07
June, 2000 EIR Leiner Health Product, Llc - EIR, 2000-06-01
September, 2003 FDA 483 The Ritedose Corporation - Form 483, 2003-09-12
January, 2000 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2000-01-14
March, 2002 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2002-03-22
November, 2015 FDA 483 Duke Clinical Research Institute - Form 483, 2015-11-04
September, 2013 EIR SC Johnson Professional USA, Inc. - EIR, 2013-09-24
February, 2006 FDA 483 Marlin Company, Inc. - Form 483, 2006-02-02
April, 2012 FDA 483 Marlin Company, Inc. - Form 483, 2012-04-18
February, 2002 EIR Albemarle Corporation - EIR, 2002-02-14
April, 2004 FDA 483 Response Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483R, 2004-04-29
December, 2002 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2002-12-12
December, 2003 EIR Ei, LLC - EIR, 2003-12-23
March, 2007 FDA 483 Response Leiner Health Product, Llc - Form 483R, 2007-04-09
July, 2003 FDA 483 Carolina Medical Inc - Form 483, 2003-07-18
January, 2000 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2000-01-14
August, 2002 EIR Crain, Jack L., M.D. - Clinical Investigator - EIR, 2002-08-14
October, 2003 EIR McKesson Corporation - EIR, 2003-10-08
February, 2002 EIR Casat, Charles D., MD - Clinical Investigator - EIR, 2002-02-26
September, 2001 EIR Walter D. Holder, MD Clinical Investigator - EIR, 2001-09-06
July, 2001 EIR Frenette, Gary MD - EIR, 2001-07-27
March, 2007 FDA 483 Leiner Health Product, Llc - Form 483, 2007-03-16
September, 2001 FDA 483 Walter D. Holder, MD Clinical Investigator - Form 483, 2001-09-06
November, 2001 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2001-11-09
February, 2002 FDA 483 Dr. Charles D. Casat - Clinical Investigator - Form 483, 2002-02-26
April, 2017 EIR BioAgilytix Labs - EIR, 2017-04-26
July, 2001 FDA 483 Frenette, Gary MD - Form 483, 2001-07-27
November, 2001 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2001-11-09
November, 2000 FDA 483 Response Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483R, 2000-11-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more